We report here the characterization of Cha, a transcription factor of the basic helix-loop-helix (bHLH) family. The basic region of Cha shares DNA interacting amino acids with members of class C bHLH transcription factors. In addition, the HLH region of Cha presents a Myc-type dimerization domain signature required for heterodimer formation between members of this class. Cha protein and mRNA was ubiquitously expressed in many human tissues. Electrophoretic mobility shift assays showed that Cha and Upstream Stimulatory Factor (USF) 1 formed a complex that specifically bound to E-box DNA elements. Moreover, pull down and co-immunoprecipitation experiments showed an interaction between Cha and USF-1. Cha did not bind to E-box DNA elements and required USF-1 for protein-DNA complex formation. Moreover, Cha inhibited USF-1 stimulated transcription of CD2 (a USF-1-dependent gene) and Ebox promoter reporter plasmids. Chromatin immunoprecipitation assays showed that Cha occupied the CD2 promoter in resting, but not in mitogen stimulated, T cells.
INTRODUCTION
A great number of transcription factors have been described and classified in several families according to the structural properties of their DNA binding domain (1) .
Among those, basic Helix Loop Helix (bHLH) DNA binding proteins are a family of proteins characterized by their ability to recognize specific DNA sequences, termed Eboxes (CANNTG) through their basic region. They are able to form homo or heterodimers via their HLH domain (2) . E-box elements were first identified in the immunoglobulin heavy-chain (IgH) intronic enhancer and have since then been found in a large number of pancreatic, lymphoid and muscle-specific promoter and enhancer elements (3) . These proteins have originally been grouped into three classes based upon structural characteristics and pattern of expression (4) . The class A proteins are ubiquitously expressed and readily bind DNA as either homodimers or heterodimers, with some of them implicated in cellular differentiation (5) (6) (7) . Class B proteins are expressed in a tissue-specific manner and form heterodimers with class A bHLH proteins. Some of these factors, as MyoD, myogenin and myf-5, are implicated in muscle development (8) (9) (10) . The last group, class C, forms homo and heterodimers with class C but not with class A or B bHLH proteins. Class A and B proteins recognize
MATERIALS AND METHODS

Cell cultures-Jurkat, Jurkat J77cl-20 clone and COS-7 cells were grown in RPMI and
Dulbeco's minimal essential medium (DMEM; Gibco, UK), respectively. The medium contained 100 µg/ml streptomycin, 100 units/ml penicillin, 2mM L-glutamine plus nonessential amino acids supplemented with 5% heat-inactivated fetal bovine serum (FBS; Gibco, UK). Incubation was carried out at 37 o C in a 7% CO 2 -in-air atmosphere, water vapor saturated incubator.
Resting T lymphocytes were purified from blood drawn from healthy volunteers and centrifuged through Ficoll-Paque (Pharmacia-Biotech, UK) as described (35) . The peripheral blood mononuclear cells (PBMC) were depleted of adherent and B cells by plastic adherence and nylon wool columns. Cells were resuspended in DMEM-10% FBS and stimulated with 20 ng/ml phorbol myristic acetate (PMA) plus 1 µM A23187 calcium ionophore (Io) (Sigma).
Cloning of Cha-Cha cDNA was isolated as described (36) . A partial sequence (pBKCMVCha) was isolated from the screening of a human cDNA library with sera from chagasic (T. cruzi-infected) patients. Later, the 5' end sequence was obtained by The CAT reporter plasmid driven by the CD2 promoter element named CM2.5
5'Rapid Amplification of cDNAs Ends (RACE). Oligonucleotides Comp (5'-G G G A A C C A T G T G C T C C G G G T G G -
was supplied by Dr. J. Owen (29) . The NF-kB Luc reporter contained three tandem repeats of the NF-κB enhancer upstream of the conalbumin minimal promoter and the luciferase reporter gene (pNF3ConA Luc) (38) . pGL3p4E-boxCD2 was constructed as In vitro protein interaction analysis-Protein expression in pGEX4T3, pGEX4T3-sCha and pGEXUSF-1 transformed E. coli DH5α strain was induced in a 20 ml culture with 100 µM IPTG for 5 h. Bacterial cells were disrupted by sonication in PBS containing 1% TritonX-100, supplemented with protesase inhibitors (2µg/ml aprotinin, 2µg/ml pepstatin, 2µg/ml leupeptin and 0,5 mM PMSF). Subsequently, the lysate was centrifuged and the supernatants containing the expression proteins glutathione-stransferase (GST) and GST-sCha were coupled to 50 µl of glutathione Sepharose 4B
(Amersham Pharmacia Biotech AB, Upsala, Sweden) for 1 h at 4ºC and washed with 10 bed volumes of ice cold PBS 1%TX-100. Recombinant proteins were purified either with reduced glutathione or thrombin cleavage, as indicated, following instructions of the manufacturer. A whole cell extract (WCE) from 15x10 6 Jurkat cells lysed in TNT (20mMTris.HCl pH 7,6, 200mM NaCl, 1% Triton X-100 suplemented with protease inhibitors), was incubated with glutathione Sepharose 4B coupled with GST for 1h at 4ºC, and then coupled with GST-sCha for 1 h at 4ºC. The resins were washed three times with 1 ml of ice cold TNT and the bound proteins were separated by SDS-PAGE followed by Western blot with the anti USF-1 antibody.
Antibodies-Specific anti-Cha antibodies were prepared by immunizing rabbits with a peptide of Cha (SLVTCPAQGSLQSSPSMEI) as described and were purified by affinity-chromatography as described (36) . Anti-Cha antibodies showed no crossreactivity against recombinant USF-1, USF-2 or protease activity (not shown).
The affinity purified antibodies used in supershifting assays directed against: USF-1, USF-2 and E12#E47 were were made against the recombinant proteins and generously provided by Dr. Carmelo Bernabéu (Centro de Investigaciones Biológicas, Madrid).
Anti-USF-1 (sc-229X) and anti Actin (1-19) (sc-1616) antibodies were from Santa
Cruz. Electrophoretic mobility shift assay (EMSA)-Nuclear extracts from Jurkat cells or peripheral blood T lymphocytes were prepared basically as described (35) . Doublestranded CD2 oligonucleotide (which contains an E-box element from human CD2
Cell transfection-Jurkat
promoter 5'-GATCAAAGAGAGGCACGTGGTTAAGCTC-3') was used as a probe.
The irrelevant oligonucleotide (5'-CCCGGAGAATACAAAAAGGTCCCTGACGG- Western blotting-WCE was made using TNT and nuclear extracts as described in previous sections. Western blot analyses were performed as described previously (35) . Oligonucleotides derived from the CD2 promoter, EboxCD2F (5'-
CTTAGGGGTTGGTTTCCTCTT-3'), oligonucleotides derived from the p53 promoter (as negative control), p53F (5'-GCTTTGTGCCAGGAGGAGCCTCCGC-3') and p53R 
Expression of CD2 in transfected cells (expressing GFP) was analyzed in a
FACSCalibur apparatus (Becton Dickinson).
RESULTS
Cha contains a Class C bHLH DNA binding domain-As result of the screening of a
Jurkat T cell line cDNA expression library with sera from Trypanosoma cruzi chronically infected patients, a clone named Cha was isolated which encodes a partial cDNA sequence (36) . The complete cDNA of Cha was obtained by 5' RACE and revealed a 5' non-coding region of 481 bp, followed by 819 bp open reading frame which codes for a protein of 273 aminoacids (Fig. 1A) . A search through the data-base found 100% homology with exons 2 to 6 of a testis specific gene, named TCFL5 (41).
Cha also presented a different 5' untranslated region ( presence of a Myc-type "helix-loop-helix" dimerization domain signature at position 208 ( Fig. 2A) . Since the aminoacid sequence of Cha basic region conserves E-box specific positions and contains a dimerization domain signature, we propose that Cha is a new member of the class C bHLH transcription factor.
Tissue expression of Cha-In order to study the expression of Cha in tissues, we performed western blot of human tissues with anti-Cha antibody. Figure 3A shows an almost ubiquitous expression pattern of Cha protein in different human tissues, except for brain. Surprisingly, the mobility of Cha varied slightly in different tissues. Antibody against actin was used as a control. However, this isoform of actin was not detected in some tissues, such as heart and skeletal muscle, because they express a different isoform of actin. Similar results were obtained using mouse tissue extracts (data not shown). In addition, human cDNA libraries from different tissues were used as templates for PCR amplification with oligonucleotides specific for the 3' end of Cha.
As shown in Fig. 3B , Cha cDNA showed a ubiquitous pattern of expression, since it was detected in all tissues studied. This was in agreement with results of Northern blot analysis of Cha mRNA from different human tissues (not shown).
Cha binds to E-box sequences-The above results prompted us to test the E-box binding activity of this protein. For this, we used the E-box sequence (CACGTG) of the CD2
promoter, a USF-1 dependent gene encoding a 55 kDa glycoprotein expressed on T cells (29) as a probe. Nuclear extracts from Jurkat T cells were used in EMSA to determine the presence of binding activities for the CD2 E-box element. A protein-DNA complex was specifically competed by the unlabelled probe but not by an irrelevant one (Fig. 4A, arrow) . This complex was completely supershifted with antibodies against USF-1 and partially with antibodies specific for USF-2.
Preincubation of the extracts with the antibody specific for Cha produced a partial reduction of the complex similar to anti USF-2 antibody (Fig. 4A) . In contrast, the complex remained basically unaltered in the presence of antibodies directed against other bHLH proteins, as E12#E47 or by rabbit preimmune serum (not shown). A nonspecific complex (although present in all lanes) appeared with more intensity in the presence of anti-Cha. However, this complex was competed by an irrelevant TATA4 oligonucleotide (Fig. 4B, asterisk) . To further investigate whether Cha and USF were part of the same complex able to bind the CD2 promoter E-box element, an in vitro translated recombinant Cha (rCha) was used in a supershifting assay. It has been described that RRL, used for the in vitro translation assay, contain USF (45). Because of this, we observed a faint basal binding complex to the CD2 E-box probe in unprogrammed lysates (Fig. 5A ). This complex was abrogated after incubation with anti-USF-1 (Fig. 5B) . A complex of similar mobility, but with stronger intensity than for unprogrammed RRL, was detected with in vitro translated rCha as a specific single complex, as it was competed by the cold CD2 oligonucleotide but not by an irrelevant oligonucleotide (Fig. 5A) . Addition of antibodies directed against Cha or against USF-1 to the binding reaction, resulted in the abrogation of the specific complex binding. As a control, the addition of anti-E12#E47
antibody did not alter the binding of the specific complex (Fig. 5A) . Thus, the above results suggested that Cha interacted with USF molecules present in the RRL to form a specific complex.
To discard the possibility that interaction between Cha and USF-1 required a third factor, and to further corroborate Cha and USF-1 ability to form a specific complex, we used highly purified recombinant Cha and USF-1 in EMSA assays. Figure 5C shows that USF-1, but not Cha, formed homodimers able to bind to the CD2 probe. Addition of Cha, but not GST, to the USF-1 binding reaction caused an increase (around two fold by densitometer scanning of the bands, not shown) in the amount of complex formed, which likely corresponded to the formation of heterodimers between USF-1 and Cha.
All the complexes were supershifted with the addition of anti-USF-1 antibody to the reaction (data not shown).
Cha and USF-1 interact "in vitro" and "in vivo"-Immunoprecipitation of Jurkat cells
with anti-USF-1 antibody followed by western blot with anti Cha and anti-USF-1
antibodies showed the presence of both USF-1 and Cha in the immunoprecipitate (Fig.   6A ). This suggests a protein interaction between Cha and USF-1. To further confirm this hypothesis we used COS-7 cells which allow high levels of protein expression in transient transfection. Figure 6B shows that untransfected COS-7 neither express detectable USF-1 nor sCha, but upon transfection, COS-7 cells showed high level of expression of both proteins. Immunoprecipitation of WCE with anti-USF-1 antibody followed by Western blot analysis with anti-Cha antibody showed that anti-USF-1 was able to coimmunoprecipitate sCha only in cells transfected with both USF-1 and sCha.
( Fig. 6C ). In addition we performed pull down experiments with GST-sCha and Jurkat WCE. Incubation of highly purified GST and GST-sCha with Glutathione Sepharose in the absence or presence of Jurkat WCE followed by Western blot with anti-USF-1 antibody showed that GST-sCha was able to pull down USF-1 (Fig.6D ), further confirming its interaction.
Cha inhibits USF dependent promoter transcription-To study the involvement of Cha in the modulation of USF activity we analyzed its effect on the expression of CD2 (a USF dependent gene). For this we co-transfected the CD2 CAT reporter plasmid with increasing amounts of Cha expression vector in Jurkat cells. Co-transfection of Cha expression plasmid resulted in a dramatic dose dependent inhibition of the basal reporter activity (Fig. 7A) . As a control, transfection of increasing amounts of Cha did not affect NF-κB Luc reporter. CD2 transcription had been shown to be enhanced by transfection of both USF-1 and Max expressing plasmids (29) . In agreement with this, we found that transfection of USF-1 alone produced a small enhancement, whereas
Max was ineffective (Fig 7B) . However, both together had a synergistic effect. This enhanced transcription was also inhibited by cotransfection of Cha in a dose dependent manner. Remarkably, very small amounts of Cha plasmid (50 ng/10 6 cells) were able to inhibit USF-1/Max dependent transcription (Fig. 7B) . Cha was also able to inhibit USF-1 dependent transcription of a tandem E-box reporter plasmid (Fig. 7C) . Furthermore, we have not found any transactivating activity promoted by Cha in assays where Gal4-Cha constructs and Gal4 luciferase reporter plasmid were cotransfected (data not shown), indicating that Cha has no intrinsic transactivating activity. Therefore, Cha was able to specifically inhibit the transactivation of USF and E-box dependent promoters. promoter region during T cell activation.
Regulation of CD2 and Cha expression during T cell activation-It
DISCUSSION
We have described here the characterization of a bHLH transcription factor named Cha. This factor belongs to the bHLH transcription factor family since it has a bona-fide bHLH domain. It is well established that the basic region of bHLH domain is essential in determining DNA binding specificity and that certain residues in this 13
aminoacid-long basic region are characteristic of particular bHLH protein classes (44). 1   gggaaccatgtgctccgggtggcattcttggatgtcagggaagcctaggaaggcccgacg  60  61  gggtttgcaggttttgagttttaaaatgaggttccagcttgcagccgcccccttggcgac  120  121  cttcagggatggctgtggaaggggctgcgtccgcagttttctgttcatcccagcctgtag  180  181  ttgcccattgtggtcacactggaggatggcaaaagtgagattggtgtcaggatgtgatga  240  241  gagcagggaggtggcgcagttttgcttttcctccataggaagaggaggacttccacagca  300  301  gcgataattgctaattgttgtgtagagatttccaggatgagagttgggttgctgtttgga  360  361  aaaactagccagagccatgggagtgggatggtggatgcttttttgccacgtattgctgac  420  421  acttctgggctttcttttgtcttggcagtttggtaactctcattcgacatccatctgaac  480  481 taatgaatgttcctcttcagcaacaaaacaaatgtacagcattagtgaaaaataaaactg 
